Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Temozolomide
100%
Autophagy
100%
Glioblastoma Cells
100%
PX-866
100%
Promote Apoptosis
100%
Glioblastoma
25%
Survival Pathways
18%
Autophagic Flux
18%
Glioma Cells
12%
Sequential Treatment
12%
PI3K Inhibitor
12%
AKT1
12%
Patient-derived Tumor Xenograft
12%
T98G
12%
Protein Expression
6%
Blood-brain Barrier
6%
Molecular Markers
6%
PI3K Signaling
6%
Vulnerability
6%
Cell Survival
6%
Autophagosome
6%
Therapeutic Potential
6%
Stress-responsive
6%
Apoptosis
6%
Co-treatment
6%
DNA Damage
6%
New Therapeutics
6%
Therapeutic Vulnerabilities
6%
Proliferating Cells
6%
Penetrant
6%
Induced Stress
6%
O6-methylguanine-DNA Methyltransferase
6%
Clonogenic Assay
6%
Colony Formation
6%
Methylguanine Methyltransferase
6%
Molecular Signaling
6%
LC3-II
6%
Pro-survival
6%
AKT Inhibitor
6%
Inherent Resistance
6%
Human Glioma Cell Line
6%
LC3 Protein
6%
Pathway Marker
6%
Opportunity to Use
6%
Clinical Responsiveness
6%
Cellular Program
6%
Medicine and Dentistry
Programmed Cell Death
100%
Autophagy
100%
Glioblastoma
100%
Temozolomide
100%
Phosphoinositide 3-Kinase
100%
Glioma Cell
12%
Tumor Xenograft
12%
Protein Expression
6%
Cell Survival
6%
Antiinfective Agent
6%
Blood Brain Barrier
6%
Cell Proliferation
6%
DNA Damage
6%
Molecular Marker
6%
Clonogenic Assay
6%
Colony Formation
6%
DNA Methyltransferase
6%
Glioma Cell Line
6%
Autophagosome
6%
Methylated DNA Protein Cysteine Methyltransferase
6%
Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase
100%
Autophagy
100%
DNA Methyltransferase
33%
Genetic Marker
16%
Protein Expression
16%
Cell Survival
16%
DNA Damage
16%
Cell Proliferation
16%
Clonogenic Assay
16%
Blood Brain Barrier
16%
Colony Formation
16%
Autophagosome
16%
6-O-Methylguanine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Temozolomide
100%
Glioblastoma
100%
Phosphatidylinositol 3 Kinase
100%
Neoplasm
12%
Antiinfective Agent
6%
Molecular Marker
6%
DNA Methyltransferase
6%
Methylated DNA Protein Cysteine Methyltransferase
6%
Blood-Brain Barrier
6%